EUVIMEDEUVIMED entdecken
Crossref

Liquid biopsy-based detection of circulating and exfoliated cholangiocarcinoma tumor cells from blood and bile using heparan sulfate octasaccharides on integrated microfluidic systems

Wei-Chun Tsai, Anandaraju Bandaru, Cheng-Hsiu Chang, Priya Gopinathan, Chih-Hung Wang, Yi-Cheng Tsai, Chien-Jui Huang, Nai-Jung Chiang, Yu-Jie Huang, Yan-Shen Shan, Shang-Cheng Hung, Gwo-Bin Lee

Methods · 2026

DOI: 10.1016/j.ymeth.2026.08.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods, 2026. Verfasst von Wei-Chun Tsai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Power Mechanical Engineering, National Tsing Hua University, Hsinchu, Taiwan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Neoplastic Cells, Circulating, Heparan Sulfate, Bile Duct Neoplasms. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early diagnosis of cholangiocarcinoma (CCA) remains challenging because existing diagnostic approaches often lack sufficient sensitivity for reliable detection of early-stage disease. Circulating tumor cells (CTCs) in blood and exfoliated tumor cells (ETCs) in bile represent valuable targets for liquid biopsy-based detection; however, their low abundance and the complexity of clinical sample analysis pose substantial technical challenges for reliable enrichment and identification. Herein, we present a reproducible workflow for isolating and identifying CCA tumor cells from blood for CTCs and bile for ETCs using synthetic cell-surface heparan sulfate (HS) octasaccharide-functionalized magnetic beads (MBs) on integrated microfluidic systems. The method combined sample pre-processing, magnetic bead-based enrichment, controlled low-shear mixing and immunofluorescence-based identification into a unified workflow compatible with distinct clinical sample types. Key operational parameters, including MB concentration, mixing frequency, and pressure settings, were detailed to facilitate consistent performance. Using this workflow, tumor cell capture rates of approximately 70% in bile (for ETCs) and blood (for CTCs) were achieved, with a total processing time of 60-90 min per sample under clinically relevant low-abundance conditions. The platform enables reliable detection of as few as 1 tumor cell per mL of blood or bile. This method provides a practical and adaptable strategy for glycosaminoglycan-mediated liquid biopsy applications and may be extended to other tumor-cell enrichment workflows involving heterogeneous cell-surface interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaNeoplastic Cells, CirculatingHeparan SulfateBile Duct NeoplasmsMicrofluidic Analytical TechniquesHumansLiquid BiopsyCell Line, TumorBileOligosaccharides

Stichwörter der Autor:innen

CholangiocarcinomaCirculating tumor cellsExfoliated tumor cellsHeparan sulfate octasaccharideIntegrated microfluidic systemLiquid biopsy

Substanzen

Heparan SulfateOligosaccharides

Autor:innen und Institutionen

  • Department of Power Mechanical Engineering, National Tsing Hua University, Hsinchu, Taiwan.
  • Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Institute of NanoEngineering and Microsystems, National Tsing Hua University, Hsinchu, Taiwan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan; Institute of Clinical Medicine, National Cheng Kung University Hospital, Tainan, Tai…
  • Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Genomics Research Center, Academia Sinica, Taipei, Taiwan; Department of Chemistry, National Tsing Hua University, Hsinchu, Taiwan. Electronic address: schung@gate.sinica.edu.tw.

Förderung

  • National Science and Technology Council

Zitieren

APA

Tsai, W. C., Bandaru, A., Chang, C. H., Gopinathan, P., Wang, C. H., Tsai, Y. C., Huang, C. J., Chiang, N. J., Huang, Y. J., Shan, Y. S., Hung, S. C., & Lee, G. B. (2026). Liquid biopsy-based detection of circulating and exfoliated cholangiocarcinoma tumor cells from blood and bile using heparan sulfate octasaccharides on integrated microfluidic systems. Methods. https://doi.org/10.1016/j.ymeth.2026.08.008

Vancouver

Tsai WC, Bandaru A, Chang CH, Gopinathan P, Wang CH, Tsai YC, et al. Liquid biopsy-based detection of circulating and exfoliated cholangiocarcinoma tumor cells from blood and bile using heparan sulfate octasaccharides on integrated microfluidic systems. Methods. 2026. doi:10.1016/j.ymeth.2026.08.008

BibTeX
@article{Tsai2026,
  author = {Tsai, Wei-Chun and Bandaru, Anandaraju and Chang, Cheng-Hsiu and Gopinathan, Priya and Wang, Chih-Hung and Tsai, Yi-Cheng and Huang, Chien-Jui and Chiang, Nai-Jung and Huang, Yu-Jie and Shan, Yan-Shen and Hung, Shang-Cheng and Lee, Gwo-Bin},
  title = {Liquid biopsy-based detection of circulating and exfoliated cholangiocarcinoma tumor cells from blood and bile using heparan sulfate octasaccharides on integrated microfluidic systems},
  journal = {Methods},
  year = {2026},
  doi = {10.1016/j.ymeth.2026.08.008}
}
Kostenlos starten →